HEADER RECORD*******LIBRARY HEADER RECORD!!!!!!!000000000000000000000000000000 SAS SAS SASLIB 6.06 MAC1. 27FEB25:10:37:2927FEB25:10:37:29 HEADER RECORD*******MEMBER HEADER RECORD!!!!!!!000000000000000001600000000140 HEADER RECORD*******DSCRPTR HEADER RECORD!!!!!!!000000000000000000000000000000 SAS _1257722SASDATA 6.06 27FEB25:10:37:2927FEB25:10:37:29 Solicited AR post D7 Analysis Dataset HEADER RECORD*******NAMESTR HEADER RECORD!!!!!!!000000008000000000000000000000 STUDYID Study Identifier USUBJID Unique Subject Identifier SUBJID Subject Identifier for the Study 'SITEID Study Site Identifier 0COUNTRY Country 5AGE Age BEST 8AGEU Age Units @AGEGR1 Pooled Age Group 1 E AGEGR1N Pooled Age Group 1 (N) BEST W AGEGR2 Pooled Age Group 2 _AGEGR2N Pooled Age Group 2 (N) BEST rSEX Sex z) RACE Race {'RACESPY Race Specify ¤ETHNIC Ethnicity ËRANDFL Randomized Population Flag áSAFFL Safety Population Flag âFASBABFLFull Analysis Set bAb Population Flag ãFASNABFLFull Analysis Set nAb Population Flag äPPBABFL Per Protocol bAb Population Flag åPPNABFL Per Protocol nAb Population Flag æPPBD29FLPer Protocol bAb Day 29 Flag çPPBD57FLPer Protocol bAb Day 57 Flag èPPND29FLPer Protocol nAb Day 29 Flag éPPND57FLPer Protocol nAb Day 57 Flag êSAR1FL First Solicited Safety Population Flag ëSAR2FL Second Solicited Safety Population Flag ìSARAFL Solicited Safety Population Flag íFASNA2FLFAS nAb 2 Population Flag îPPNAB2FLPP nAb 2 Population Flag ïPN2D29FLPer Protocol nAb 2 Day 29 Flag ð PN2D57FLPer Protocol nAb 2 Day 57 Flag ñ!COMPLFL Completers Population Flag ò"DVBABFL Deviation Impact bAb Flag ó#DVNABFL Deviation Impact nAb Flag ô$DOSE1FL Vaccination 1 Flag õ%DOSE2FL Vaccination 2 Flag ö&DOSEROFLDosing Error Flag ÷'COV19BL Baseline COVID Infection ø(COV19FL COVID Infection Flag )SENTLFL Sentinel Participant Flag *D29W7DFLDay 29 Out of 7-Day Window Flag +TRT01P Planned Treatment for Period 01 ,TRT01PN Planned Treatment for Period 01 (N) BEST -TRT01A Actual Treatment for Period 01 .TRT01AN Actual Treatment for Period 01 (N) BEST //TR01SDT Date of First Exposure in Period 01 DATE 70TR01SDTMDatetime of First Exposure in Period 01 DATETIME ?1TR01EDT Date of Last Exposure in Period 01 DATE G2TR01EDTMDatetime of Last Exposure in Period 01 DATETIME O3TRTSDTM Datetime of First Exposure to Treatment DATETIME W4TRTEDTM Datetime of Last Exposure to Treatment DATETIME _5DOSE2DT Date of Dose 2 DATE g6DOS2DTM Datetime of Dose 2 DATETIME o7TRTA Actual Treatment w8TRTAN Actual Treatment (N) BEST ‡9ASEQ Analysis Sequence Number BEST :ASTDT Analysis Start Date DATE —;ASTTM Analysis Start Time TIME ŸAENDT Analysis End Date DATE ·?AENTM Analysis End Time TIME ¿@AENDTM Analysis End Datetime DATETIME ÇAAENDY Analysis End Relative Day BEST Ï BATPTREF Analysis Timepoint Reference ×CARRDSTPTStart Timepoint from Most Recent Dose äDARRDENPTEnd Timepoint from Most Recent Dose é(EPARCAT1 Parameter Category 1 ïFPARCAT1NParameter Category 1 (N) BEST GPARAMCD Parameter Code ^HPARAM Parameter 'IAVAL Analysis Value BEST …^JAVALC Analysis Value (C) KATOXGR Analysis Toxicity Grade ëLATOXGRN Analysis Toxicity Grade (N) BEST òMANL01FL Analysis Flag 01 úNADURN Analysis Duration (N) BEST û OFAEVAL Evaluator PMAAEFL Medically Attended Flag HEADER RECORD*******OBS HEADER RECORD!!!!!!!000000000000000000000000000000 mRNA-1273-P201mRNA-1273-P201-US201-1007US2011007US201USABEYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNYNPlacebo APlacebo ADV3Hq¥dDVOHqÉäHq¥dHqÉäDVOHqÉäPlacebo AADV:E”Hq®@A€DV<..A Vaccination 1DAY 8DAY 10LOCAL AERYTHDIAErythema Longest Diameter (mm) .GRADE 1/MILD Grade 1AYA0INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US201-1060US2011060US201USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADV4Hq¦@ DVPHqËb$Hq¦@ HqËb$DVPHqËb$Placebo AADV;E¶ÀHq¯ÓìA€DV=E>€Hq²¯hA Vaccination 1DAY 8DAY 10SYSTEMIC A RASHOCC Rash Occurrence .Y .YA0STUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADV4Hq¦hDVPHqË,Hq¦hHqË,DVPHqË,Placebo AADVWDÄàHqÔw`B$DVZE7HqØêpB'Vaccination 2DAY 8DAY 11LOCAL APAIN Pain .GRADE 1/MILD Grade 1A A@INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADV4Hq¦hDVPHqË,Hq¦hHqË,DVPHqË,Placebo AA DVWE…ÀHqÔúÜB$DV[HqØø€B(Vaccination 2DAY 8DAY 11LOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AYA@STUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADV4Hq¦hDVPHqË,Hq¦hHqË,DVPHqË,Placebo AA0DVW..B$DV_..B,Vaccination 2DAY 8DAY 16LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AYAINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US201-1084US2011084US201USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE HISPANIC OR LATINO YYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq¦ÌDVPHqÊìôHq¦ÌHqÊìôDVPHqÊìômRNA-1273 50 ug A ADVXB´HqÕ´B%DVZD7Hq×ÞB'Vaccination 2DAY 8DAY 10SYSTEMIC A RASHOCC Rash Occurrence .Y .YA0STUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqÆ DVhHqëHqÆ HqëDVhHqëmRNA-1273 50 ug A ADVSEHHqÏ‘A€DVdE<ÀHqåùÌBVaccination 1DAY 8DAY 25SYSTEMIC A ARTHRALGArthralgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A YBSTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqÆ DVhHqëHqÆ HqëDVhHqëmRNA-1273 50 ug A A DVo..B$DVo..B$Vaccination 2DAY 8DAY 8 SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AYAINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqÆ DVhHqëHqÆ HqëDVhHqëmRNA-1273 50 ug A A0DVSED@HqÏÄA€DVVExÀHqÓˆŒA°Vaccination 1DAY 8DAY 11SYSTEMIC A MYALGIA Myalgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A YA@STUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqÆ DVhHqëHqÆ HqëDVhHqëmRNA-1273 50 ug A A@DVo..B$DVo..B$Vaccination 2DAY 8DAY 8 SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AYAINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3Hq¤ëDVPHqËÌHq¤ëHqËÌDVPHqËÌmRNA-1273 50 ug A ADV:..A€DVB..BVaccination 1DAY 8DAY 16SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1A AINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3Hq¤ëDVPHqËÌHq¤ëHqËÌDVPHqËÌmRNA-1273 50 ug A A DV:DÍŒHq®DŒA€DVBD®œHq¸±œBVaccination 1DAY 8DAY 16SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A YASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3Hq¤ëDVPHqËÌHq¤ëHqËÌDVPHqËÌmRNA-1273 50 ug A A0DV:..A€DV;..AVaccination 1DAY 8DAY 9 SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1A A INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3Hq¤ëDVPHqËÌHq¤ëHqËÌDVPHqËÌmRNA-1273 50 ug A A@DV:DÍŒHq®DŒA€DV:DÍŒHq®DŒA€Vaccination 1DAY 8DAY 8 SYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERERENCE WITH ACTIVITYGrade 2A YASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7HqªPDVWHqÔ68HqªPHqÔ68DVWHqÔ68mRNA-1273 50 ug A ADV^E¨€HqÞ'ˆB(DV^E¨€HqÞ'ˆB(Vaccination 2DAY 8DAY 8 SYSTEMIC A ARTHRALGArthralgia .GRADE 3/SEVERE Grade 3A0YAINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7HqªPDVWHqÔ68HqªPHqÔ68DVWHqÔ68mRNA-1273 50 ug A A DV^EÀHqÞìB(DV_D¨ÀHqÞç@B)Vaccination 2DAY 8DAY 9 SYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0YA INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7HqªPDVWHqÔ68HqªPHqÔ68DVWHqÔ68mRNA-1273 50 ug A A0DV^E¨€HqÞ'ˆB(DV^E¨€HqÞ'ˆB(Vaccination 2DAY 8DAY 8 SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1A ASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7HqªPDVWHqÔ68HqªPHqÔ68DVWHqÔ68mRNA-1273 50 ug A A@DV^E¨€HqÞ'ˆB(DV^E¨€HqÞ'ˆB(Vaccination 2DAY 8DAY 8 SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AYASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7HqªPDVWHqÔ68HqªPHqÔ68DVWHqÔ68mRNA-1273 50 ug A APDV^E¨€HqÞ'ˆB(DV^E¨€HqÞ'ˆB(Vaccination 2DAY 8DAY 8 SYSTEMIC A MYALGIA Myalgia .GRADE 3/SEVERE Grade 3A0YAINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqªVØDVXHqÕ‰ HqªVØHqÕ‰ DVXHqÕ‰ mRNA-1273 100 ugA0ADV>Eø@Hq³ì„A€DVDDxHq»AàVaccination 1DAY 8DAY 14SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1A ApINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqªVØDVXHqÕ‰ HqªVØHqÕ‰ DVXHqÕ‰ mRNA-1273 100 ugA0A DV>E‚Hq´ A€DVCDkXHq¹¿ØAÐVaccination 1DAY 8DAY 12SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AYAPSTUDY SUBJECTYmRNA-1273-P201mRNA-1273-P201-US202-1096US2021096US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADV5Hq§¨ DVRHqÍÞ<Hq§¨ HqÍÞ<DVRHqÍÞ<Placebo AADVY..B%DVZ..B&Vaccination 2DAY 8DAY 9 SYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0YA INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US202-1096US2021096US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADV5Hq§¨ DVRHqÍÞ<Hq§¨ HqÍÞ<DVRHqÍÞ<Placebo AA DVYEVHq×ŠàB%DVYEVHq×ŠàB%Vaccination 2DAY 8DAY 8 SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1A ASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYNYYYYYYN NNYYNNot DetectedNNNPlacebo APlacebo ADV7Hqª"XDVVHqÒ÷xHqª"XHqÒ÷xDVVHqÒ÷xPlacebo AADV>EÁHq³ÙA€DV@De@HqµÅ@A Vaccination 1DAY 8DAY 10SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1A A0INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYNYYYYYYN NNYYNNot DetectedNNNPlacebo APlacebo ADV7Hqª"XDVVHqÒ÷xHqª"XHqÒ÷xDVVHqÒ÷xPlacebo AA DV>DæÜHq³£ÜA€DV>DæÜHq³£ÜA€Vaccination 1DAY 8DAY 8 SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AYASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYNYYYYYYN NNYYNNot DetectedNNNPlacebo APlacebo ADV7Hqª"XDVVHqÒ÷xHqª"XHqÒ÷xDVVHqÒ÷xPlacebo AA0DV>EÁHq³ÙA€DV@Dm°HqµÍ°A Vaccination 1DAY 8DAY 10SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1A A0INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYNYYYYYYN NNYYNNot DetectedNNNPlacebo APlacebo ADV7Hqª"XDVVHqÒ÷xHqª"XHqÒ÷xDVVHqÒ÷xPlacebo AA@DV>DæÜHq³£ÜA€DV>DæÜHq³£ÜA€Vaccination 1DAY 8DAY 8 SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AYASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYNYYYYYYN NNYYNNot DetectedNNNPlacebo APlacebo ADV7Hqª"XDVVHqÒ÷xHqª"XHqÒ÷xDVVHqÒ÷xPlacebo AAPDV>..A€DV@..A Vaccination 1DAY 8DAY 10SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1A A0INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYNYYYYYYN NNYYNNot DetectedNNNPlacebo APlacebo ADV7Hqª"XDVVHqÒ÷xHqª"XHqÒ÷xDVVHqÒ÷xPlacebo AA`DV>DæÜHq³£ÜA€DV>DæÜHq³£ÜA€Vaccination 1DAY 8DAY 8 SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AYASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US202-1154US2021154US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqªLLDVXHqÕÔ˜HqªLLHqÕÔ˜DVXHqÕÔ˜mRNA-1273 100 ugA0ADV_EfHqßdàB)DV`D¨ÀHqà8ÀB*Vaccination 2DAY 8DAY 9 SYSTEMIC A HEADACHEHeadache .GRADE 3/SEVERE Grade 3A0YA INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US202-1154US2021154US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqªLLDVXHqÕÔ˜HqªLLHqÕÔ˜DVXHqÕÔ˜mRNA-1273 100 ugA0A DV_DÀäHqÞÿdB)DV_DÀäHqÞÿdB)Vaccination 2DAY 8DAY 8 SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1A ASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US202-1164US2021164US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqøœDVXHqÕHHqøœHqÕHDVXHqÕHmRNA-1273 100 ugA0ADVADý Hq·® A€DVCE>ÀHqºXlA Vaccination 1DAY 8DAY 10LOCAL ALYMPH Lymphadenopathy .DOES NOT INTERFERE WITH ACTIVITY Grade 1AYA0STUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US202-1164US2021164US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqøœDVXHqÕHHqøœHqÕHDVXHqÕHmRNA-1273 100 ugA0A DVA..A€DVD..A°Vaccination 1DAY 8DAY 11LOCAL APAIN Pain .GRADE 1/MILD Grade 1AYA@INVESTIGATOR YmRNA-1273-P201mRNA-1273-P201-US202-1175US2021175US202USAB$YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADV:Hq®BpDVXHqÕ±¬Hq®BpHqÕ±¬DVXHqÕ±¬Placebo AADV_Eé@HqßmB&DVaDÇìHqá©lB(Vaccination 2DAY 8DAY 10SYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0YA0INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US202-1175US2021175US202USAB$YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADV:Hq®BpDVXHqÕ±¬Hq®BpHqÕ±¬DVXHqÕ±¬Placebo AA DV`DrØHqàØB'DV`DrØHqàØB'Vaccination 2DAY 8DAY 8 SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A ASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US202-1179US2021179US202USAB&YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV:Hq®LÀDVWHqÔ‡Hq®LÀHqÔ‡DVWHqÔ‡mRNA-1273 50 ug A ADVAE@Hq·ÒôA€DVBDí0Hq¸ð0AVaccination 1DAY 8DAY 9 SYSTEMIC A RASHOCC Rash Occurrence .Y .YA STUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:Hq®gDVXHqÕ(Hq®gHqÕ(DVXHqÕ(mRNA-1273 100 ugA0ADVA..A€DVQ..BVaccination 1DAY 8DAY 24LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AYBINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:Hq®gDVXHqÕ(Hq®gHqÕ(DVXHqÕ(mRNA-1273 100 ugA0A DV_EuHqßeÐB&DVaD~Hqá`B(Vaccination 2DAY 8DAY 10LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AYA0INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US202-1208US2021208US202USAB8YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYNYNYYYYYYN NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHqÌ¨ DVmHqñ™0HqÌ¨ Hqñ™0DVmHqñ™0mRNA-1273 100 ugA0ADVtDõ Hqúã B$DVxDÃ´Hqÿ÷´B(Vaccination 2DAY 8DAY 12SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1A APINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US202-1208US2021208US202USAB8YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYNYNYYYYYYN NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHqÌ¨ DVmHqñ™0HqÌ¨ Hqñ™0DVmHqñ™0mRNA-1273 100 ugA0A DVtEÂHqúú B$DVwD©tHqþ‹ôB'Vaccination 2DAY 8DAY 11SYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERERENCE WITH ACTIVITYGrade 2A YA@STUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US202-1217US2021217US202USABBYEARS>=55 Years A >=55 Years A@FWHITE NOT REPORTED YYYYYYYYYNYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVOHqÉÖDVmHqñmÔHqÉÖHqñmÔDVmHqñmÔmRNA-1273 50 ug A ADVtDædHqúÔdB&DVtDædHqúÔdB&Vaccination 2DAY 8DAY 8 SYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0YAINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US202-1217US2021217US202USABBYEARS>=55 Years A >=55 Years A@FWHITE NOT REPORTED YYYYYYYYYNYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVOHqÉÖDVmHqñmÔHqÉÖHqñmÔDVmHqñmÔmRNA-1273 50 ug A A DVVEðÀHqÓA€DVVEðÀHqÓA€Vaccination 1DAY 8DAY 8 SYSTEMIC A RASHOCC Rash Occurrence .Y .YASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US203-1004US2031004US203USABYEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV0Hq¡€DVOHqÉ®pHq¡€HqÉ®pDVOHqÉ®pmRNA-1273 50 ug A ADVVDý HqÓ^ B'DVWDŒ HqÔ? B(Vaccination 2DAY 8DAY 9 LOCAL APAIN Pain .GRADE 3/SEVERE Grade 3A0YA INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq©ÄDVVHqÓ-ØHq©ÄHqÓ-ØDVVHqÓ-ØmRNA-1273 50 ug A ADV]D©8HqÜD¸B(DV]D©8HqÜD¸B(Vaccination 2DAY 8DAY 8 SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AYASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq©ÄDVVHqÓ-ØHq©ÄHqÓ-ØDVVHqÓ-ØmRNA-1273 50 ug A A DV]D½$HqÜX¤B(DVaE(Hqâ$B,Vaccination 2DAY 8DAY 12SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1A APINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq©ÄDVVHqÓ-ØHq©ÄHqÓ-ØDVVHqÓ-ØmRNA-1273 50 ug A A0DV]D¨üHqÜD|B(DVaD¨ÀHqáŠ@B,Vaccination 2DAY 8DAY 12SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AYAPSTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US203-1074US2031074US203USAB4YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADV4Hq¦}ÄDVPHqËPTHq¦}ÄHqËPTDVPHqËPTPlacebo AADVWEVHqÔçàB$DVXDý HqÖ B%Vaccination 2DAY 8DAY 9 SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1A A INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US203-1074US2031074US203USAB4YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADV4Hq¦}ÄDVPHqËPTHq¦}ÄHqËPTDVPHqËPTPlacebo AA DVWDåtHqÔ—ôB$DVYE¢Hq× B&Vaccination 2DAY 8DAY 10SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AYA0STUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US203-1091US2031091US203USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqÅÍ(DVkHqî£ìHqÅÍ(Hqî£ìDVkHqî£ìmRNA-1273 100 ugA0ADVrDp€Hq÷»€B'DVrDp€Hq÷»€B'Vaccination 2DAY 8DAY 8 SYSTEMIC A HEADACHEHeadache .GRADE 3/SEVERE Grade 3A0YAINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US203-1105US2031105US203USABCYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqÅµDVlHqïåôHqÅµHqïåôDVlHqïåômRNA-1273 50 ug A ADVS..A€DVY..AàVaccination 1DAY 8DAY 14SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1A ApINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US203-1105US2031105US203USABCYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqÅµDVlHqïåôHqÅµHqïåôDVlHqïåômRNA-1273 50 ug A A DVSDè€HqÏUA€DVYEê@Hq×t$AàVaccination 1DAY 8DAY 14SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AYApSTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US204-1008US2041008US204USAB%YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYNYNYYYYYYN NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3Hq¥ÄDVQHqÌ©THq¥ÄHqÌ©TDVQHqÌ©TmRNA-1273 100 ugA0ADVX..B&DVZ..B(Vaccination 2DAY 8DAY 10SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1A A0INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US204-1008US2041008US204USAB%YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYNYNYYYYYYN NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3Hq¥ÄDVQHqÌ©THq¥ÄHqÌ©TDVQHqÌ©TmRNA-1273 100 ugA0A DVXE…HqÖPB&DVXE…HqÖPB&Vaccination 2DAY 8DAY 8 SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AYASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US204-1060US2041060US204USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYNYYYYYYN NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4Hq¦lDVQHqÌNdHq¦lHqÌNdDVQHqÌNdmRNA-1273 100 ugA0ADV;..A€DV;..A€Vaccination 1DAY 8DAY 8 LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AYAINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4Hq¦„DVPHqËa4Hq¦„HqËa4DVPHqËa4mRNA-1273 100 ugA0ADV;D‡xHq¯OøA€DV>D±¨Hq³n¨A°Vaccination 1DAY 8DAY 11SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1A A@INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4Hq¦„DVPHqËa4Hq¦„HqËa4DVPHqËa4mRNA-1273 100 ugA0A DV;DílHq¯µìA€DV>D½œHq³zœA°Vaccination 1DAY 8DAY 11SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A YA@STUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4Hq¦„DVPHqËa4Hq¦„HqËa4DVPHqËa4mRNA-1273 100 ugA0A0DVW..B$DV[..B(Vaccination 2DAY 8DAY 12SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1A APINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4Hq¦„DVPHqËa4Hq¦„HqËa4DVPHqËa4mRNA-1273 100 ugA0A@DVWDâ,HqÔ”¬B$DVZD«HqØRB'Vaccination 2DAY 8DAY 11SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A YA@STUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq¦6DVVHqÓŒHq¦6HqÓŒDVVHqÓŒmRNA-1273 50 ug A ADV;DïHq¯·A€DV=EVHq² àA Vaccination 1DAY 8DAY 10SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1A A0INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq¦6DVVHqÓŒHq¦6HqÓŒDVVHqÓŒmRNA-1273 50 ug A A DV;Dù$Hq¯Á¤A€DV=DñàHq²]`A Vaccination 1DAY 8DAY 10SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A YA0STUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq¦6DVVHqÓŒHq¦6HqÓŒDVVHqÓŒmRNA-1273 50 ug A A0DV]E?€HqÜÏxB*DViDÍHqì:”B6Vaccination 2DAY 8DAY 20SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A YAÐSTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq¦6DVVHqÓŒHq¦6HqÓŒDVVHqÓŒmRNA-1273 50 ug A A@DV;..A€DV>..A°Vaccination 1DAY 8DAY 11SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1A A@INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq¦6DVVHqÓŒHq¦6HqÓŒDVVHqÓŒmRNA-1273 50 ug A APDV;DøèHq¯ÁhA€DV=DñàHq²]`A Vaccination 1DAY 8DAY 10SYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERERENCE WITH ACTIVITYGrade 2A YA0STUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq¦6DVVHqÓŒHq¦6HqÓŒDVVHqÓŒmRNA-1273 50 ug A A`DV]D½ØHqÜYXB*DV_..B,Vaccination 2DAY 8DAY 10SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1A A0INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq¦6DVVHqÓŒHq¦6HqÓŒDVVHqÓŒmRNA-1273 50 ug A ApDV]E?€HqÜÏxB*DV^DþˆHqÝëˆB+Vaccination 2DAY 8DAY 9 SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AYA STUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq¦6DVVHqÓŒHq¦6HqÓŒDVVHqÓŒmRNA-1273 50 ug A A€DV]D½ØHqÜYXB*DV^D½ØHqÝªØB+Vaccination 2DAY 8DAY 9 SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1A A INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq¦6DVVHqÓŒHq¦6HqÓŒDVVHqÓŒmRNA-1273 50 ug A ADV]E?€HqÜÏxB*DV]E?€HqÜÏxB*Vaccination 2DAY 8DAY 8 SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AYASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US204-1126US2041126US204USAB>YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqÅåLDVlHqïÿDHqÅåLHqïÿDDVlHqïÿDmRNA-1273 100 ugA0ADVS..A€DVT..AVaccination 1DAY 8DAY 9 SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1A A INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US204-1126US2041126US204USAB>YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqÅåLDVlHqïÿDHqÅåLHqïÿDDVlHqïÿDmRNA-1273 100 ugA0A DVSEÀHqÏ}ŒA€DVSEÀHqÏ}ŒA€Vaccination 1DAY 8DAY 8 SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AYASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US204-1155US2041155US204USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYYYYYNY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVVHqÓ;¬DVrHqødHqÓ;¬HqødDVrHqødmRNA-1273 50 ug A ADVyEÀHr…¬B$DVzD¸ìHrìB%Vaccination 2DAY 8DAY 9 SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1A A INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US204-1155US2041155US204USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYYYYYNY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVVHqÓ;¬DVrHqødHqÓ;¬HqødDVrHqødmRNA-1273 50 ug A A DVyD¸ìHr>lB$DVyD¸ìHr>lB$Vaccination 2DAY 8DAY 8 SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AYASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYNYYYYYYN NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq© €DVWHqÔBàHq© €HqÔBàDVWHqÔBàmRNA-1273 50 ug A ADV^..B)DV_..B*Vaccination 2DAY 8DAY 9 SYSTEMIC A ARTHRALGArthralgia .GRADE 3/SEVERE Grade 3A0YA INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYNYYYYYYN NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq© €DVWHqÔBàHq© €HqÔBàDVWHqÔBàmRNA-1273 50 ug A A DV^..B)DV_..B*Vaccination 2DAY 8DAY 9 SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1A A INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYNYYYYYYN NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq© €DVWHqÔBàHq© €HqÔBàDVWHqÔBàmRNA-1273 50 ug A A0DV^EÂHqÝù B)DV_DépHqß'ðB*Vaccination 2DAY 8DAY 9 SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A YA STUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqÅ¹DVhHqêšHqÅ¹HqêšDVhHqêšmRNA-1273 50 ug A ADVoDŒ Hqóã B$DVtHqùîB)Vaccination 2DAY 8DAY 13LOCAL APAIN Pain .GRADE 2/MODERATE Grade 2A YA`INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqÅ¹DVhHqêšHqÅ¹HqêšDVhHqêšmRNA-1273 50 ug A A DVoD«Hqô˜B$DVsD«HqùHB(Vaccination 2DAY 8DAY 12LOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1A APSTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqÅ¹DVhHqêšHqÅ¹HqêšDVhHqêšmRNA-1273 50 ug A A0DVS..A€DVV..A°Vaccination 1DAY 8DAY 11SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1A A@INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqÅ¹DVhHqêšHqÅ¹HqêšDVhHqêšmRNA-1273 50 ug A A@DVSDÇìHqÏ4lA€DVVDV|HqÒ·|A°Vaccination 1DAY 8DAY 10SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AYA0STUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqÅ¹DVhHqêšHqÅ¹HqêšDVhHqêšmRNA-1273 50 ug A APDVS..A€DVX..AÐVaccination 1DAY 8DAY 13SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1A A`INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqÅ¹DVhHqêšHqÅ¹HqêšDVhHqêšmRNA-1273 50 ug A A`DVSDÇìHqÏ4lA€DVWD¯ÈHqÔbHAÀVaccination 1DAY 8DAY 12SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AYAPSTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqÅ¹DVhHqêšHqÅ¹HqêšDVhHqêšmRNA-1273 50 ug A ApDVo..B$DVo..B$Vaccination 2DAY 8DAY 8 SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1A AINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqÅ¹DVhHqêšHqÅ¹HqêšDVhHqêšmRNA-1273 50 ug A A€DVoD«Hqô˜B$DVoD«Hqô˜B$Vaccination 2DAY 8DAY 8 SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AYASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqÅ¹DVhHqêšHqÅ¹HqêšDVhHqêšmRNA-1273 50 ug A ADVo..B$DVo..B$Vaccination 2DAY 8DAY 8 SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1A AINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqÅ¹DVhHqêšHqÅ¹HqêšDVhHqêšmRNA-1273 50 ug A A DVoD«Hqô˜B$DVoD«Hqô˜B$Vaccination 2DAY 8DAY 8 SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AYASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHqË:DVlHqð°HqË:Hqð°DVlHqð°mRNA-1273 50 ug A ADVsEÉ€Hqù©B$DVsEÉ€Hqù©B$Vaccination 2DAY 8DAY 8 SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1A AINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHqË:DVlHqð°HqË:Hqð°DVlHqð°mRNA-1273 50 ug A A DVsEÉ€Hqù©B$DVsEÉ€Hqù©B$Vaccination 2DAY 8DAY 8 SYSTEMIC A ARTHRALGArthralgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A YASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHqË:DVlHqð°HqË:Hqð°DVlHqð°mRNA-1273 50 ug A A0DVsEÅÀHqù¨ÜB$DVsEÅÀHqù¨ÜB$Vaccination 2DAY 8DAY 8 SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1A AINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHqË:DVlHqð°HqË:Hqð°DVlHqð°mRNA-1273 50 ug A A@DVsEÅÀHqù¨ÜB$DVsEÅÀHqù¨ÜB$Vaccination 2DAY 8DAY 8 SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AYASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHqË:DVlHqð°HqË:Hqð°DVlHqð°mRNA-1273 50 ug A APDVsEÉ€Hqù©B$DVsEÉ€Hqù©B$Vaccination 2DAY 8DAY 8 SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1A AINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHqË:DVlHqð°HqË:Hqð°DVlHqð°mRNA-1273 50 ug A A`DVsEÉ€Hqù©B$DVsEÉ€Hqù©B$Vaccination 2DAY 8DAY 8 SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AYASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US205-1069US2051069US205USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqÅôLDVlHqïäŒHqÅôLHqïäŒDVlHqïäŒmRNA-1273 100 ugA0ADVSHqÎl€A€DVSHqÎl€A€Vaccination 1DAY 8DAY 8 SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1A AINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US205-1069US2051069US205USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqÅôLDVlHqïäŒHqÅôLHqïäŒDVlHqïäŒmRNA-1273 100 ugA0A DVSEtHqÏ£ÀA€DVSEtHqÏ£ÀA€Vaccination 1DAY 8DAY 8 SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AYASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq§ª<DVVHqÒèHq§ª<HqÒèDVVHqÒèmRNA-1273 100 ugA0ADV]E”HqÜ´ÀB)DVmE”HqñÌÀB9Vaccination 2DAY 8DAY 24SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1A BINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq§ª<DVVHqÒèHq§ª<HqÒèDVVHqÒèmRNA-1273 100 ugA0A DV]E@HqÜÓtB)DVmEHqñõB9Vaccination 2DAY 8DAY 24SYSTEMIC A ARTHRALGArthralgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A YBSTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq§ª<DVVHqÒèHq§ª<HqÒèDVVHqÒèmRNA-1273 100 ugA0A0DV]DT`HqÛïàB)DV^DbpHqÝOpB*Vaccination 2DAY 8DAY 9 SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1A A INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq§ª<DVVHqÒèHq§ª<HqÒèDVVHqÒèmRNA-1273 100 ugA0A@DV]EƒHqÜÓ°B)DV]EƒHqÜÓ°B)Vaccination 2DAY 8DAY 8 SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AYASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US206-1015US2061015US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADV5Hq§±¼DVVHqÓ-$Hq§±¼HqÓ-$DVVHqÓ-$Placebo AADV<..A€DV<..A€Vaccination 1DAY 8DAY 8 SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1A AINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US206-1015US2061015US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADV5Hq§±¼DVVHqÓ-$Hq§±¼HqÓ-$DVVHqÓ-$Placebo AA DV<ExÀHq±AŒA€DV<ExÀHq±AŒA€Vaccination 1DAY 8DAY 8 SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AYASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US206-1015US2061015US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADV5Hq§±¼DVVHqÓ-$Hq§±¼HqÓ-$DVVHqÓ-$Placebo AA0DV<ExÀHq±AŒA€DV<ExÀHq±AŒA€Vaccination 1DAY 8DAY 8 SYSTEMIC A HEADACHEHeadache .ANY USE OF PRESCRIPTION PAIN RELIEVER OR PREVENTS DAILY ACTIVITY Grade 3A0YASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US206-1023US2061023US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOYYYYYYYYYNYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7Hqª% DVVHqÒèðHqª% HqÒèðDVVHqÒèðmRNA-1273 100 ugA0ADV>Dì¸Hq³©¸A€DV>Dì¸Hq³©¸A€Vaccination 1DAY 8DAY 8 LOCAL ALYMPH Lymphadenopathy .DOES NOT INTERFERE WITH ACTIVITY Grade 1AYASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US206-1023US2061023US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOYYYYYYYYYNYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7Hqª% DVVHqÒèðHqª% HqÒèðDVVHqÒèðmRNA-1273 100 ugA0A DV>..A€DV>..A€Vaccination 1DAY 8DAY 8 LOCAL APAIN Pain .GRADE 1/MILD Grade 1AYAINVESTIGATOR YmRNA-1273-P201mRNA-1273-P201-US206-1023US2061023US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOYYYYYYYYYNYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7Hqª% DVVHqÒèðHqª% HqÒèðDVVHqÒèðmRNA-1273 100 ugA0A0DV]..B'DVb..B,Vaccination 2DAY 8DAY 13SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1A A`INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US206-1023US2061023US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOYYYYYYYYYNYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7Hqª% DVVHqÒèðHqª% HqÒèðDVVHqÒèðmRNA-1273 100 ugA0A@DV^DlHHqÝYHB(DVaE@Hqâ2ÄB+Vaccination 2DAY 8DAY 12SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AYAPSTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADVOHqÉýäDVkHqîà(HqÉýäHqîà(DVkHqîà(Placebo AADVrDý HqøH B$DVrDý HqøH B$Vaccination 2DAY 8DAY 8 SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1A AINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADVOHqÉýäDVkHqîà(HqÉýäHqîà(DVkHqîà(Placebo AA DVrE¿Hqø†ðB$DVuCxHqûGB'Vaccination 2DAY 8DAY 10SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AYA0STUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADVOHqÉýäDVkHqîà(HqÉýäHqîà(DVkHqîà(Placebo AA0DVrDý HqøH B$DVrDý HqøH B$Vaccination 2DAY 8DAY 8 SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1A AINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADVOHqÉýäDVkHqîà(HqÉýäHqîà(DVkHqîà(Placebo AA@DVrE¿Hqø†ðB$DVrE¿Hqø†ðB$Vaccination 2DAY 8DAY 8 SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AYASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADVOHqÉýäDVkHqîà(HqÉýäHqîà(DVkHqîà(Placebo AAPDVrDý HqøH B$DVrDý HqøH B$Vaccination 2DAY 8DAY 8 SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1A AINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADVOHqÉýäDVkHqîà(HqÉýäHqîà(DVkHqîà(Placebo AA`DVrE¿Hqø†ðB$DVrE¿Hqø†ðB$Vaccination 2DAY 8DAY 8 SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AYASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US206-1051US2061051US206USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADVPHqËdDVnHqòê8HqËdHqòê8DVnHqòê8Placebo AADVW..A€DVW..A€Vaccination 1DAY 8DAY 8 SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AYAINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3Hq¤áDVPHqË:Hq¤áHqË:DVPHqË:mRNA-1273 100 ugA0ADVW..B%DVW..B%Vaccination 2DAY 8DAY 8 LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AYAINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3Hq¤áDVPHqË:Hq¤áHqË:DVPHqË:mRNA-1273 100 ugA0A DVWDp€HqÔ#B%DVXDp€HqÕt€B&Vaccination 2DAY 8DAY 9 SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AYA INVESTIGATOR YmRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3Hq¤áDVPHqË:Hq¤áHqË:DVPHqË:mRNA-1273 100 ugA0A0DVWEíHqÔáPB%DVpEâÀHqõÆ,B>Vaccination 2DAY 8DAY 33SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A YBSTUDY SUBJECTYmRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3Hq¤áDVPHqË:Hq¤áHqË:DVPHqË:mRNA-1273 100 ugA0A@DVWE”HqÔËÀB%DV\Dp€HqÚº€B*Vaccination 2DAY 8DAY 13SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1A A`INVESTIGATOR YmRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3Hq¤áDVPHqË:Hq¤áHqË:DVPHqË:mRNA-1273 100 ugA0APDVWEíHqÔáPB%DVbE‡ÀHqã[|B0Vaccination 2DAY 8DAY 19SYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERERENCE WITH ACTIVITYGrade 2A YAÀSTUDY SUBJECTYmRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3Hq¤áDVPHqË:Hq¤áHqË:DVPHqË:mRNA-1273 100 ugA0A`DVW..B%DVY..B'Vaccination 2DAY 8DAY 10SYSTEMIC A NAUSEA Nausea/Vomiting .GRADE 1/MILD Grade 1A A0INVESTIGATOR YmRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3Hq¤áDVPHqË:Hq¤áHqË:DVPHqË:mRNA-1273 100 ugA0ApDVWEðÀHqÔáŒB%DVXEm€HqÖ*ØB&Vaccination 2DAY 8DAY 9 SYSTEMIC A NAUSEA Nausea/Vomiting .NO INTERFERENCE WITH ACTIVITY OR 1-2 EPISODES/24 HOURS Grade 1AYA STUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq¨µ¨DVXHqÕ†ÈHq¨µ¨HqÕ†ÈDVXHqÕ†ÈmRNA-1273 50 ug A ADV_..B*DV`..B+Vaccination 2DAY 8DAY 9 SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1A A INVESTIGATOR YmRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq¨µ¨DVXHqÕ†ÈHq¨µ¨HqÕ†ÈDVXHqÕ†ÈmRNA-1273 50 ug A A DV_EßHqß\pB*DVfDdŒHqçÝŒB1Vaccination 2DAY 8DAY 14SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A YApSTUDY SUBJECTYmRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq¨µ¨DVXHqÕ†ÈHq¨µ¨HqÕ†ÈDVXHqÕ†ÈmRNA-1273 50 ug A A0DV_Dp€HqÞ¯B*DV`..B+Vaccination 2DAY 8DAY 9 SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1A A INVESTIGATOR YmRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq¨µ¨DVXHqÕ†ÈHq¨µ¨HqÕ†ÈDVXHqÕ†ÈmRNA-1273 50 ug A A@DV_EÛ@Hqß\4B*DVfDdŒHqçÝŒB1Vaccination 2DAY 8DAY 14SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AYApSTUDY SUBJECTYmRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq¨µ¨DVXHqÕ†ÈHq¨µ¨HqÕ†ÈDVXHqÕ†ÈmRNA-1273 50 ug A APDV_..B*DV_..B*Vaccination 2DAY 8DAY 8 SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AYAINVESTIGATOR YmRNA-1273-P201mRNA-1273-P201-US207-1022US2071022US207USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADV5Hq§Œ´DVRHqÍ´üHq§Œ´HqÍ´üDVRHqÍ´üPlacebo AADV<..A€DV<..A€Vaccination 1DAY 8DAY 8 LOCAL ALYMPH Lymphadenopathy .GRADE 1/MILD Grade 1A AINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US207-1022US2071022US207USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADV5Hq§Œ´DVRHqÍ´üHq§Œ´HqÍ´üDVRHqÍ´üPlacebo AA DV<DÖìHq°ðìA€DV<DÖìHq°ðìA€Vaccination 1DAY 8DAY 8 LOCAL ALYMPH Lymphadenopathy .DOES NOT INTERFERE WITH ACTIVITY Grade 1AYASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US207-1085US2071085US207USABKYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADVLHqÆôDVlHqð)tHqÆôHqð)tDVlHqð)tPlacebo AADVSDöTHqÏbÔA€DVUDþHqÒ A Vaccination 1DAY 8DAY 10SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AYA0STUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US207-1100US2071100US207USAB=YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADVVHqÓC,DVsHqù4$HqÓC,Hqù4$DVsHqù4$Placebo AADV{DS¬Hr|,B&DV{ExÀHrPB&Vaccination 2DAY 8DAY 9 SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AYA STUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US208-1057US2081057US208USAB-YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADV7HqªCÜDVYHq×THqªCÜHq×TDVYHq×TPlacebo AADV>..A€DV>..A€Vaccination 1DAY 8DAY 8 LOCAL ALYMPH Lymphadenopathy .GRADE 1/MILD Grade 1A AINVESTIGATOR YmRNA-1273-P201mRNA-1273-P201-US208-1057US2081057US208USAB-YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADV7HqªCÜDVYHq×THqªCÜHq×TDVYHq×TPlacebo AA DV>DÅ”Hq³‚”A€DV>DÅ”Hq³‚”A€Vaccination 1DAY 8DAY 8 LOCAL ALYMPH Lymphadenopathy .DOES NOT INTERFERE WITH ACTIVITY Grade 1AYASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US208-1057US2081057US208USAB-YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADV7HqªCÜDVYHq×THqªCÜHq×TDVYHq×TPlacebo AA0DV>..A€DV>..A€Vaccination 1DAY 8DAY 8 SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1A AINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US208-1057US2081057US208USAB-YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNPlacebo APlacebo ADV7HqªCÜDVYHq×THqªCÜHq×TDVYHq×TPlacebo AA@DV>DÅ”Hq³‚”A€DV>DÅ”Hq³‚”A€Vaccination 1DAY 8DAY 8 SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AYASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US208-1069US2081069US208USABFYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqÆˆDVhHqêäÜHqÆˆHqêäÜDVhHqêäÜmRNA-1273 100 ugA0ADVS..A€DVS..A€Vaccination 1DAY 8DAY 8 SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1A AINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US208-1069US2081069US208USABFYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqÆˆDVhHqêäÜHqÆˆHqêäÜDVhHqêäÜmRNA-1273 100 ugA0A DVSE´ÀHqÏ—ÌA€DVSE´ÀHqÏ—ÌA€Vaccination 1DAY 8DAY 8 SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AYASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US208-1076US2081076US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHqÌV DVtHqú¸HqÌV Hqú¸DVtHqú¸mRNA-1273 100 ugA0ADV{..B+DV|..B,Vaccination 2DAY 8DAY 9 LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AYA INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqÍôDVoHqô¸HqÍôHqô¸DVoHqô¸mRNA-1273 50 ug A ADVY..A€DV^..AÐVaccination 1DAY 8DAY 13SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1A A`INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqÍôDVoHqô¸HqÍôHqô¸DVoHqô¸mRNA-1273 50 ug A A DVYDùœHq×OA€DV^DpøHqÝ]øAÐVaccination 1DAY 8DAY 12SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AYAPSTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqÍôDVoHqô¸HqÍôHqô¸DVoHqô¸mRNA-1273 50 ug A A0DVYDùœHq×OA€DV[DºÌHqÙ³LA Vaccination 1DAY 8DAY 10SYSTEMIC A RASHOCC Rash Occurrence .Y .YA0STUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYYYYYYN NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqÅ®8DVmHqñ$ðHqÅ®8Hqñ$ðDVmHqñ$ðmRNA-1273 100 ugA0ADVuDJHqû‰B*DVzDúÈHrÑÈB/Vaccination 2DAY 8DAY 14SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AYApSTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYYYYYYN NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqÅ®8DVmHqñ$ðHqÅ®8Hqñ$ðDVmHqñ$ðmRNA-1273 100 ugA0A DVuDIÔHqû‰TB*DVvEÞHqý¾àB+Vaccination 2DAY 8DAY 10SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AYA0STUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNNNYYYYYYN NYYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqÍÝÄDVrHq÷ÙHqÍÝÄHq÷ÙDVrHq÷ÙmRNA-1273 50 ug A ADVY..A€DVY..A€Vaccination 1DAY 8DAY 8 SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1A AINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNNNYYYYYYN NYYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqÍÝÄDVrHq÷ÙHqÍÝÄHq÷ÙDVrHq÷ÙmRNA-1273 50 ug A A DVYD«Hq×A€DVYD«Hq×A€Vaccination 1DAY 8DAY 8 SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AYASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNNNYYYYYYN NYYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqÍÝÄDVrHq÷ÙHqÍÝÄHq÷ÙDVrHq÷ÙmRNA-1273 50 ug A A0DVy..B(DVz..B)Vaccination 2DAY 8DAY 9 SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1A A INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNNNYYYYYYN NYYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqÍÝÄDVrHq÷ÙHqÍÝÄHq÷ÙDVrHq÷ÙmRNA-1273 50 ug A A@DVyD¯ÈHr5HB(DVzD¬€Hrƒ€B)Vaccination 2DAY 8DAY 9 SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AYA STUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNNNYYYYYYN NYYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqÍÝÄDVrHq÷ÙHqÍÝÄHq÷ÙDVrHq÷ÙmRNA-1273 50 ug A APDVY..A€DV[..A Vaccination 1DAY 8DAY 10SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1A A0INVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNNNYYYYYYN NYYYNNot DetectedNNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqÍÝÄDVrHq÷ÙHqÍÝÄHq÷ÙDVrHq÷ÙmRNA-1273 50 ug A A`DVYD«THq×ÔA€DV[D¨üHqÙ¡|A Vaccination 1DAY 8DAY 10SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AYA0STUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqÍù¨DVrHqø¤HqÍù¨Hqø¤DVrHqø¤mRNA-1273 100 ugA0ADVy..B(DVy..B(Vaccination 2DAY 8DAY 8 SYSTEMIC A FATIGUE Fatigue .GRADE 2/MODERATE Grade 2A AINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqÍù¨DVrHqø¤HqÍù¨Hqø¤DVrHqø¤mRNA-1273 100 ugA0A DVyD©°Hr/0B(DVyD©°Hr/0B(Vaccination 2DAY 8DAY 8 SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A YASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqÍù¨DVrHqø¤HqÍù¨Hqø¤DVrHqø¤mRNA-1273 100 ugA0A0DVy..B(DVy..B(Vaccination 2DAY 8DAY 8 SYSTEMIC A HEADACHEHeadache .GRADE 2/MODERATE Grade 2A YAINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqÍù¨DVrHqø¤HqÍù¨Hqø¤DVrHqø¤mRNA-1273 100 ugA0A@DVyD©°Hr/0B(DVyD©°Hr/0B(Vaccination 2DAY 8DAY 8 SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1A ASTUDY SUBJECT mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqÍù¨DVrHqø¤HqÍù¨Hqø¤DVrHqø¤mRNA-1273 100 ugA0APDVy..B(DVy..B(Vaccination 2DAY 8DAY 8 SYSTEMIC A NAUSEA Nausea/Vomiting .GRADE 2/MODERATE Grade 2A YAINVESTIGATOR mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYYYYYYY NNYYNNot DetectedNNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqÍù¨DVrHqø¤HqÍù¨Hqø¤DVrHqø¤mRNA-1273 100 ugA0A`DVyD©°Hr/0B(DVyD©°Hr/0B(Vaccination 2DAY 8DAY 8 SYSTEMIC A NAUSEA Nausea/Vomiting .NO INTERFERENCE WITH ACTIVITY OR 1-2 EPISODES/24 HOURS Grade 1A ASTUDY SUBJECT